Indical acquires Svanova from Boehringer Ingelheim

April 1, 2021

Indical has acquired the Svanova product portfolio from Boehringer Ingelheim. Through the acquisition, Indical becomes the exclusive provider of Svanova’s veterinary testing products, which include around 25 livestock ELISA assays.

Svanova arose out of the Swedish Veterinary Institute, a pioneer in veterinary diagnostic solutions for eradication programmes and disease monitoring. Initially, Svanova’s products were primarily used in Sweden. Since then, the company has expanded to meet the global demand for quality diagnostic solutions and today sells to 70+ countries.

Recent news

Fidelio forms Vimian – a global powerhouse …

Following a decade of successfully shaping market leaders across the rapidly evolving animal health market, Fidelio Capital AB (Fidelio) today announced the formation of Vimian – a global and diversified group of innovation-driven companies operating in four fast-growing animal health

Read more

PDL expands to Norway

PDL enters Norway by establishing two padel destinations in the Oslo region with 25 padel courts in total. PDL has secured a substantial number of further locations across the country, which are due to open later this year. The expansion

Read more

Fidelio establishes Movora, a global leader in th…

With the formation of Movora, Fidelio establishes a global leader in the veterinary orthopedic market. Movora consists of three brands; Kyon (Switzerland), BioMedtrix (USA) and VOI (USA), acquired by Fidelio during 2019 and 2020. Movora has 8 offices in 5

Read more